Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.
It can be hard to explain to these patients why their vision has changed and what they can expect from the available presbyopia treatment options. The good news? Four optometrists who see many of these patients have got you covered with successful patient-facing scripts.
27.2% of participants treated with phentolamine ophthalmic solution 0.75% achieved at least a 15-letter improvement in binocular DCNVA, with less than a 5-letter loss in binocular BCDVA at 12 hours postdose on Day 8, compared with 11.5% of patients on placebo (P < .001).
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Optometric Management
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Contact lenses can often meet the vision, comfort, and lifestyle needs of various patient populations, but such patients may be unaware of the benefits. One solution is to craft scripts that can educate patients and broach the subject of contact lens wear.